Table 1.
Risk profile of study patients with ACS.
| Group I (n = 68) | Group II (n = 110) | Group III (n = 75) | |
|---|---|---|---|
| Age in years (mean ±SD) | 33.2 ± 2.9 | 50.2 ± 4.8* | 69.3 ± 3.5** |
| Male | 64 (94.1%) | 70 (72.7%)* | 60 (80%)* |
| Female | 4 (5.9%) | 40 (27.3%)* | 15 (20%)* |
| BMI > 25 kg/m2 (%) | 32 (47%) | 74 (67%)* | 50 (67%)* |
| Smoking (%) | 54 (79%) | 40 (36%)* | 32 (42%)* |
| Hypertension (%) | 15 (23%) | 55 (59%)* | 49 (65%)* |
| Diabetes mellitus (%) | 5 (7%) | 33 (30%)* | 40 (53%)**^ |
| Positive FH (%) | 30 (44%) | 22 (20%)* | 10 (13%)* |
| Hypercholesterolemia (%) | 26 (38%) | 50 (45%)* | 35 (47%)* |
| Hypertriglyceredemia (%) | 36 (53%) | 40 (36%)* | 30 (40%)* |
| Low HDL (%) | 52 (76%) | 51 (46%)* | 45 (60%)*^ |
Abbreviations: BMI, body mass index; UA, unstable angina; NSTEMI, non ST elevation myocardial infarction; STEMI, ST elevation myocardial infarction; ACEI, angiotensin converting enzyme inhibitor.
*
gp II and III vs. I, P < 0.01.
**
gp II and III vs. I, P < 0.001.
^
grp III vs. II, P < 0.01.